Synopsis
Synopsis
0
CEP/COS
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cerespan
2. Hydrochloride, Papaverine
3. Papaverine
4. Pavabid
5. Pavatym
1. 61-25-6
2. Cardoverina
3. Cardiospan
4. Papaversan
5. Artegodan
6. Forpavin
7. Papalease
8. Pavatest
9. Pavabid
10. Dispamil
11. Drapavel
12. Paverolan
13. Alapav
14. Cerebid
15. Delapav
16. Dilaves
17. Durapav
18. Dynovas
19. Myobid
20. Pameion
21. Papacon
22. Pavacap
23. Pavacen
24. Paveron
25. Pavnell
26. Vasal
27. Papaverine Hcl
28. Ro-papav
29. Vaso-pav
30. 1-(3,4-dimethoxybenzyl)-6,7-dimethoxyisoquinoline Hydrochloride
31. Cerespan
32. Papaverinium Chloride
33. Papanerin-hcl
34. Papavarine Chlorhydrate
35. Pap-kaps-150
36. Papaverine Chlorohydrate
37. Papaverine, Hcl
38. Pap H
39. Papaverine (hydrochloride)
40. Papaverine Monohydrochloride
41. Nci-c56359
42. Vasorin
43. Chlorhydrate De Papaverine
44. Nsc 35443
45. 6,7-dimethoxy-1-veratrylisoquinoline Hydrochloride
46. Nsc-35443
47. Mls000028497
48. 23473ec6bq
49. Cepaverin
50. Optenyl
51. Pavagrant
52. Pavakey
53. Pavased
54. Smr000058283
55. Therapav
56. Dipav
57. Lapav
58. Dsstox_cid_5825
59. Spasmo-nit
60. Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, Hydrochloride
61. Dsstox_rid_77939
62. Dsstox_gsid_25825
63. Papanerin-hcl [german]
64. 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline;hydrochloride
65. Nsc35443
66. Ccris 3804
67. Cas-61-25-6
68. Sr-01000003098
69. Chlorhydrate De Papaverine [french]
70. Ncgc00015810-02
71. Einecs 200-502-1
72. Pamelon
73. Unii-23473ec6bq
74. Papaverine Hydrochloride [jan]
75. Qua Bid
76. Prestwick_376
77. Papaverine Hydrochloride [usp:jan]
78. Pavabid (tn)
79. Component Of Copavin
80. Mfcd00012745
81. Isoquinoline, 6,7-dimethoxy-1-veratryl-, Hydrochloride
82. 6,7,3',4'-tetramethoxy-1-benzylisoquinoline Hydrochloride
83. Papaverini Hydrochloridum
84. Papaverine, Hydrochloride
85. Opera_id_1617
86. Regid_for_cid_6084
87. Mls001148655
88. Mls002222208
89. Chembl98123
90. Schembl121268
91. Spectrum1500459
92. Papaverine Hydrochloride, Powder
93. Dtxsid9025825
94. Cas 61-25-6
95. Hms1569f08
96. Hms1920f06
97. Pharmakon1600-01500459
98. Tox21_110226
99. Tox21_500957
100. Ccg-40065
101. Hy-18077a
102. Nsc757256
103. Papaverine Hydrochloride [mi]
104. Papaverine Hydrochloride (jp17/usp)
105. Akos005111070
106. Tox21_110226_1
107. Cs-5015
108. Lp00957
109. Nsc-757256
110. Papaverine Hydrochloride [hsdb]
111. Papaverine Hydrochloride [mart.]
112. Papaverine Hydrochloride [vandf]
113. Ncgc00015810-12
114. Ncgc00094258-01
115. Ncgc00094258-02
116. Ncgc00094258-03
117. Ncgc00094258-04
118. Ncgc00094258-05
119. Ncgc00094258-06
120. Ncgc00261642-01
121. Papaverine Hydrochloride [usp-rs]
122. Papaverine Hydrochloride [who-dd]
123. Papaverine Hydrochloride [who-ip]
124. As-13262
125. 1-(3,7-dimethoxyisoquinoline Hydrochloride
126. Db-053821
127. Eu-0100957
128. P0016
129. D02218
130. D86684
131. P 3510
132. Papaverine Hydrochloride [ep Monograph]
133. Papaverine Hydrochloride [usp Monograph]
134. Papaverini Hydrochloridum [who-ip Latin]
135. Isoquinoline,7-dimethoxy-1-veratryl-, Hydrochloride
136. Sr-01000003098-2
137. Sr-01000003098-4
138. Sr-01000003098-9
139. Wln: T66 Cnj B1r Co1 Do1& Ho1 Io1 &gh
140. Q27253713
141. Sr-01000003098-11
142. 6,3',4'-tetramethoxy-1-benzylisoquinoline Hydrochloride
143. 1-(3,4-dimethoxybenzyl)-6,7-dimethoxyisoquinolinehydrochloride
144. Isoquinoline,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, Hydrochloride
145. Papaverine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
146. Papaverine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
147. Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, Hydrochloride (1:1)
148. Papaverine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
149. Papaverine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 375.8 g/mol |
---|---|
Molecular Formula | C20H22ClNO4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 375.1237359 g/mol |
Monoisotopic Mass | 375.1237359 g/mol |
Topological Polar Surface Area | 49.8 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 407 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Phosphodiesterase Inhibitors
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
Date of Issue : 2021-06-03
Valid Till : 2024-02-07
Written Confirmation Number : WC-301n
Address of the Firm :
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3633
Submission : 1979-10-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2426
Submission : 1975-03-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3309
Submission : 1978-06-15
Status : Inactive
Type : II
Registration Number : 231MF10018
Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY
Initial Date of Registration : 2019-01-29
Latest Date of Registration :
NDC Package Code : 12711-7480
Start Marketing Date : 2001-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
Brand Name : papaverine Recip
Dosage Form : TABLET
Dosage Strength : 40 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Papaverine Hydrochloride
Dosage Form :
Dosage Strength : 5 Vials 30 Mg 2Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Papaverine Hydrochloride
Dosage Form :
Dosage Strength : 5 Vials 30 Mg 2 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Papaverine Hydrochloride
Dosage Form :
Dosage Strength : 5 Vials 30 Mg 2 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Papaverine Hydrochloride
Dosage Form :
Dosage Strength : 5 Vials 50 Mg 3Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Papaverine Hydrochloride
Dosage Form :
Dosage Strength : 5 Vials 50 Mg 3 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Papaverine Hydrochloride
Dosage Form :
Dosage Strength : 5 Vials 50 Mg 3 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Papaverine He\\\'
Dosage Form :
Dosage Strength : 10 Vials Im 2 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Ethical
Registration Country : Canada
Brand Name : PAPAVERINE HYDROCHLORIDE INJECTION USP
Dosage Form : LIQUID
Dosage Strength : 65MG/2ML
Packaging : 2ML
Approval Date :
Application Number : 9881
Regulatory Info : Ethical
Registration Country : Canada
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Papaverine 60
Dosage Form : INJ
Dosage Strength : 60mg/2 ml
Packaging : 2X5mg/2 ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Global Sales Information
Market Place
Reply
23 Apr 2024
Reply
10 Jul 2023
Reply
04 Feb 2023
Reply
06 Jul 2022
Reply
06 Jul 2022
Reply
04 Jul 2022
Reply
12 Feb 2022
Reply
29 Jul 2020
Reply
21 Jul 2020
Reply
30 Jun 2020
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
15
PharmaCompass offers a list of Papaverine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Papaverine Hydrochloride manufacturer or Papaverine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Papaverine Hydrochloride manufacturer or Papaverine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Papaverine Hydrochloride API Price utilized in the formulation of products. Papaverine Hydrochloride API Price is not always fixed or binding as the Papaverine Hydrochloride Price is obtained through a variety of data sources. The Papaverine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pavased manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pavased, including repackagers and relabelers. The FDA regulates Pavased manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pavased API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pavased manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pavased supplier is an individual or a company that provides Pavased active pharmaceutical ingredient (API) or Pavased finished formulations upon request. The Pavased suppliers may include Pavased API manufacturers, exporters, distributors and traders.
click here to find a list of Pavased suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pavased DMF (Drug Master File) is a document detailing the whole manufacturing process of Pavased active pharmaceutical ingredient (API) in detail. Different forms of Pavased DMFs exist exist since differing nations have different regulations, such as Pavased USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pavased DMF submitted to regulatory agencies in the US is known as a USDMF. Pavased USDMF includes data on Pavased's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pavased USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pavased suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pavased Drug Master File in Japan (Pavased JDMF) empowers Pavased API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pavased JDMF during the approval evaluation for pharmaceutical products. At the time of Pavased JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pavased suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pavased Drug Master File in Korea (Pavased KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pavased. The MFDS reviews the Pavased KDMF as part of the drug registration process and uses the information provided in the Pavased KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pavased KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pavased API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pavased suppliers with KDMF on PharmaCompass.
A Pavased written confirmation (Pavased WC) is an official document issued by a regulatory agency to a Pavased manufacturer, verifying that the manufacturing facility of a Pavased active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pavased APIs or Pavased finished pharmaceutical products to another nation, regulatory agencies frequently require a Pavased WC (written confirmation) as part of the regulatory process.
click here to find a list of Pavased suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pavased as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pavased API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pavased as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pavased and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pavased NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pavased suppliers with NDC on PharmaCompass.
Pavased Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pavased GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pavased GMP manufacturer or Pavased GMP API supplier for your needs.
A Pavased CoA (Certificate of Analysis) is a formal document that attests to Pavased's compliance with Pavased specifications and serves as a tool for batch-level quality control.
Pavased CoA mostly includes findings from lab analyses of a specific batch. For each Pavased CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pavased may be tested according to a variety of international standards, such as European Pharmacopoeia (Pavased EP), Pavased JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pavased USP).